Literature DB >> 21640330

The role of breast cancer stem cells in metastasis and therapeutic implications.

Marco A Velasco-Velázquez1, Vladimir M Popov, Michael P Lisanti, Richard G Pestell.   

Abstract

Cancer stem cells (CSCs) possess the capacity to self-renew and to generate heterogeneous lineages of cancer cells that comprise tumors. A substantial body of evidence supports a model in which CSCs play a major role in the initiation, maintenance, and clinical outcome of cancers. In contrast, analysis of the role of CSCs in metastasis has been mainly conceptual and speculative. This review summarizes recent data that support the theory of CSCs as the source of metastatic lesions in breast cancer, with a focus on the key role of the microenvironment in the stemness-metastasis link.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21640330      PMCID： PMC3123864          DOI： 10.1016/j.ajpath.2011.03.005

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


  106 in total

1.  Cancer stem cells and the cell cycle: targeting the drive behind breast cancer.

Authors:  Marco A Velasco-Velázquez; Zuoren Yu; Xuanmao Jiao; Richard G Pestell
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

2.  Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors.

Authors:  H Ling; J-R Sylvestre; P Jolicoeur
Journal:  Oncogene       Date:  2010-06-21       Impact factor: 9.867

3.  The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.

Authors:  Kongming Wu; Sanjay Katiyar; Agnes Witkiewicz; Anping Li; Peter McCue; Liang-Nian Song; Lifeng Tian; Ming Jin; Richard G Pestell
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

4.  Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.

Authors:  Gloria Bonuccelli; Mathew C Casimiro; Federica Sotgia; Chenguang Wang; Manran Liu; Sanjay Katiyar; Jie Zhou; Elliott Dew; Franco Capozza; Kristin M Daumer; Carlo Minetti; Janet N Milliman; Fabien Alpy; Marie-Christine Rio; Catherine Tomasetto; Isabelle Mercier; Neal Flomenberg; Philippe G Frank; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2009-05       Impact factor: 4.307

Review 5.  ABC transporters, drug resistance, and cancer stem cells.

Authors:  Michael Dean
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-02-18       Impact factor: 2.673

6.  Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo.

Authors:  Manran Liu; Xiaoming Ju; Nicole E Willmarth; Mathew C Casimiro; John Ojeifo; Toshiyuki Sakamaki; Sanjay Katiyar; Xuanmao Jiao; Vladimir M Popov; Zuoren Yu; Kongming Wu; David Joyce; Chenguang Wang; Richard G Pestell
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

7.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

Authors:  Patrick C Hermann; Stephan L Huber; Tanja Herrler; Alexandra Aicher; Joachim W Ellwart; Markus Guba; Christiane J Bruns; Christopher Heeschen
Journal:  Cell Stem Cell       Date:  2007-09-13       Impact factor: 24.633

8.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Authors:  Christophe Ginestier; Min Hee Hur; Emmanuelle Charafe-Jauffret; Florence Monville; Julie Dutcher; Marty Brown; Jocelyne Jacquemier; Patrice Viens; Celina G Kleer; Suling Liu; Anne Schott; Dan Hayes; Daniel Birnbaum; Max S Wicha; Gabriela Dontu
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

9.  Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

Authors:  Emmanuelle Charafe-Jauffret; Christophe Ginestier; Flora Iovino; Julien Wicinski; Nathalie Cervera; Pascal Finetti; Min-Hee Hur; Mark E Diebel; Florence Monville; Julie Dutcher; Marty Brown; Patrice Viens; Luc Xerri; François Bertucci; Giorgio Stassi; Gabriela Dontu; Daniel Birnbaum; Max S Wicha
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

Review 10.  Migratory neighbors and distant invaders: tumor-associated niche cells.

Authors:  Jared Wels; Rosandra N Kaplan; Shahin Rafii; David Lyden
Journal:  Genes Dev       Date:  2008-03-01       Impact factor: 11.361
View more
  74 in total

1.  Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells.

Authors:  Irida Kastrati; Loruhama Delgado-Rivera; Gergana Georgieva; Gregory R J Thatcher; Jonna Frasor
Journal:  J Vis Exp       Date:  2017-01-18       Impact factor: 1.355

2.  Histone Butyrylation/ Acetylation Remains Unchanged in Triple Negative Breast Cancer Cells after a Long Term Metabolic Reprogramming.

Authors:  Fatemeh Mehdikhani; Hossein Ghahremani; Saeedeh Nabati; Hanieh Tahmouri; Majid Sirati-Sabet; Siamak Salami
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

3.  A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.

Authors:  Po-Shun Wang; Cheng-Han Chou; Cheng-Han Lin; Yun-Chin Yao; Hui-Chuan Cheng; Hao-Yi Li; Yu-Chung Chuang; Chia-Ning Yang; Luo-Ping Ger; Yu-Chia Chen; Forn-Chia Lin; Tang-Long Shen; Michael Hsiao; Pei-Jung Lu
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

4.  Tocopherols inhibit estrogen-induced cancer stemness and OCT4 signaling in breast cancer.

Authors:  Min Ji Bak; Philip Furmanski; Naing Lin Shan; Hong Jin Lee; Cheng Bao; Yong Lin; Weichung Joe Shih; Chung S Yang; Nanjoo Suh
Journal:  Carcinogenesis       Date:  2018-07-30       Impact factor: 4.944

Review 5.  Breast cancer stem cells.

Authors:  Marco A Velasco-Velázquez; Nora Homsi; Marisol De La Fuente; Richard G Pestell
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

6.  Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer.

Authors:  Kerri-Ann Norton; Aleksander S Popel; Niranjan B Pandey
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

7.  A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.

Authors:  Seyyed Mehdi Jafari; Hamid Reza Joshaghani; Mojtaba Panjehpour; Mahmoud Aghaei
Journal:  Cell Oncol (Dordr)       Date:  2017-12-07       Impact factor: 6.730

Review 8.  Phytochemicals: Current strategies for treating breast cancer.

Authors:  Bridg'ette B Israel; Syreeta L Tilghman; Kitani Parker-Lemieux; Florastina Payton-Stewart
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

Review 9.  Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Roy A Jensen; Shrikant Anant
Journal:  Semin Cancer Biol       Date:  2016-09-05       Impact factor: 15.707

10.  Tissue Stiffness and Hypoxia Modulate the Integrin-Linked Kinase ILK to Control Breast Cancer Stem-like Cells.

Authors:  Mei-Fong Pang; Michael J Siedlik; Siyang Han; Melody Stallings-Mann; Derek C Radisky; Celeste M Nelson
Journal:  Cancer Res       Date:  2016-08-08       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.